Title of article
Effect of ADRB2 polymorphisms on response to longacting β2-agonist therapy: a pharmacogenetic analysis of two randomised studies
Author/Authors
Eugene R Bleecker، نويسنده , , Dirkje S Postma، نويسنده , , Rachael M Lawrance، نويسنده , , Deborah A Meyers، نويسنده , , Helen J Ambrose، نويسنده , , Mitch Goldman، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
2118
To page
2125
Abstract
Background
New evidence has suggested that people with asthma who are homozygous for arginine at aminoacid 16 of the β2-adrenergic receptor (ADRB2) might not benefit from longacting β2-agonist therapy. We, therefore, investigated whether ADRB2 polymorphis
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
592293
Link To Document